Statistical issues in drug development
Saved in:
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Chichester, England ; Hoboken, NJ :
John Wiley & Sons,
c2007.
|
| Edition: | 2nd ed. |
| Series: | Statistics in practice.
|
| Subjects: | |
| Online Access: | An electronic book accessible through the World Wide Web; click to view |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000nam a22000004a 4500 | ||
|---|---|---|---|
| 001 | 0000100746 | ||
| 005 | 20171002055226.0 | ||
| 006 | m u | ||
| 007 | cr cn||||||||| | ||
| 008 | 071101s2007 enka sb 001 0 eng | ||
| 010 | |z 2007045553 | ||
| 016 | 7 | |z 101319993 |2 DNLM | |
| 020 | |z 9780470018774 (cloth : alk. paper) | ||
| 020 | |z 0470018771 (cloth : alk. paper) | ||
| 035 | |a (CaPaEBR)ebr10232744 | ||
| 035 | |a (OCoLC)646751242 | ||
| 040 | |a CaPaEBR |c CaPaEBR | ||
| 050 | 1 | 4 | |a RM301.25 |b .S46 2007eb |
| 082 | 0 | 4 | |a 615/.190727 |2 22 |
| 100 | 1 | |a Senn, Stephen. | |
| 245 | 1 | 0 | |a Statistical issues in drug development |h [electronic resource] / |c Stephen Senn. |
| 250 | |a 2nd ed. | ||
| 260 | |a Chichester, England ; |a Hoboken, NJ : |b John Wiley & Sons, |c c2007. | ||
| 300 | |a xix, 498 p. : |b ill. | ||
| 490 | 1 | |a Statistics in practice | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a A brief and superficial history of statistics for drug developers -- Design and interpretation of clinical trials as seen by a statistician -- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals -- The work of the pharmaceutical statistician -- Allocating treatments to patients in clinical trials -- Baselines and covariate information -- | |
| 505 | 0 | |a The measurement of treatment effects -- Demographic subgroups : representation and analysis -- Multiplicity -- Intention to treat, missing data and related matters -- One-sided and two-sided tests and other issues to do with significance and P-values -- Determining the sample size -- Multicentre trials -- Active control equivalence studies -- | |
| 505 | 0 | |a Meta-analysis -- Cross-over trials -- n-of-1 trials -- Sequential trials -- Dose-finding -- Concerning pharmacokinetics and pharmacodynamics -- Bioequivalence studies -- Safety data, harms, drug monitoring, and pharmaco-epidemiology -- Pharmaco-economics and portfolio management -- Concerning pharmacogenetics, pharmacogenomics, and related matters. | |
| 533 | |a Electronic reproduction. |b Palo Alto, Calif. : |c ebrary, |d 2013. |n Available via World Wide Web. |n Access may be limited to ebrary affiliated libraries. | ||
| 650 | 0 | |a Drug development |x Statistical methods. | |
| 655 | 7 | |a Electronic books. |2 local | |
| 710 | 2 | |a ebrary, Inc. | |
| 830 | 0 | |a Statistics in practice. | |
| 856 | 4 | 0 | |u http://site.ebrary.com/lib/daystar/Doc?id=10232744 |z An electronic book accessible through the World Wide Web; click to view |
| 908 | |a 170314 | ||
| 942 | 0 | 0 | |c EB |
| 999 | |c 89899 |d 89899 | ||